Predictive factors for adverse pregnancy outcomes in women with rheumatic valvular heart disease: A single‐center retrospective analysis
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70595 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Soniya Dhiman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Heart Valve Diseases. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objective
To analyze maternal and perinatal outcomes in women with rheumatic valvular heart disease and to evaluate the predictive factors for adverse cardiac outcomes in this cohort.
Methods
A retrospective analysis was performed of pregnant women with rheumatic heart disease (RHD) who delivered at a tertiary care referral hospital over a 5‐year period from 2018 to 2023.
Results
A total of 118 pregnant women with RHD were encountered during the study period. The mitral valve was most commonly affected (75/118; 62.7%), 79/118 (66.9%) underwent cardiac interventions, and 39/118 (33%) were on anticoagulation medication. Deterioration in New York Heart Association (NYHA) functional class was noted in 36/118 (30.5%) of these women prenatally, and cardiac failure developed in 18/118 (15.3%). New‐onset arrhythmia occurred in 6/118 (5.1%), which was managed medically. Mean gestational age at delivery was 36.73 ± 2.53 weeks, with a cesarean delivery rate of 68/118 (57.6%). Among fetal and neonatal outcomes, average birth weight was 2390.46 ± 574.46 g, with 38/118 (32.2%) being preterm and 61/118 (52.5%) being low birth weight. Key predictors of poor cardiac outcomes included more than one affected valve and a poor NYHA functional class (more than II) at admission. Patients with mechanical heart valves faced higher risks from anticoagulation.
Conclusion
Pregnancy in women with RHD is associated with adverse maternal cardiac, obstetrical, and neonatal outcomes. More than one affected heart valve and a poor NYHA functional class were found to be strong predictors of adverse cardiac outcomes during pregnancy. A specialized cardio‐obstetric team is crucial for enhancing pregnancy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Akanksha Gupta
Zitieren
APA
Dhiman, S., Sharma, K. A., Dadhwal, V., Gupta, A., Kulshrestha, V., Kadiyani, L., Vatsa, R., Bharti, J., Khan, M. A., & Malhotra, N. (2025). Predictive factors for adverse pregnancy outcomes in women with rheumatic valvular heart disease: A single‐center retrospective analysis. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70595
Vancouver
Dhiman S, Sharma KA, Dadhwal V, Gupta A, Kulshrestha V, Kadiyani L, et al. Predictive factors for adverse pregnancy outcomes in women with rheumatic valvular heart disease: A single‐center retrospective analysis. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70595
BibTeX
@article{Dhiman2025,
author = {Dhiman, Soniya and Sharma, K Aparna and Dadhwal, Vatsla and Gupta, Akanksha and Kulshrestha, Vidushi and Kadiyani, Lamk and Vatsa, Richa and Bharti, Juhi and Khan, Maroof A and Malhotra, Neena},
title = {Predictive factors for adverse pregnancy outcomes in women with rheumatic valvular heart disease: A single‐center retrospective analysis},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70595}
}
EUVIMED